In this trial, 342 men with sildenafil-failure ED were given either intranasal PT-141 (10 mg dose) or placebo on demand over ~48 weeks.The outcomes demonstrated a clear benefit of bremelanotide: About 33.5% of men on bremelanotide achieved a positive clinical response (improved erections sufficient for intercourse) compared to only 8.5% on placebo
It also elevated the level of antioxidant enzymes
Full combined protocols, reported combined ranges, sequencing, and the blend-dosing calculator are in a future paid Stack Lab module
mass 743.92 mg Single vial 10-pack Discover more
Other treatments like low-level light therapy, PRP injections, and supplements may also be effective, especially when combined
According to the time of formation: Immature scars are most often red and slightly raised, only becoming flat over time